NCT00169637View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

June 30, 2008

Conditions
Short Bowel Syndrome
Interventions
DRUG

rhGH

Trial Locations (1)

69437

Alain LACHAUX, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT00169637 - Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome | Biotech Hunter | Biotech Hunter